PubRank

H Döhner

Author PubWeight™ 141.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010 13.59
2 Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997 8.27
3 Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993 2.64
4 Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia 2004 2.08
5 DNMT3A mutations in myeloproliferative neoplasms. Leukemia 2011 1.95
6 Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia 2009 1.92
7 Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 1998 1.81
8 High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia 2005 1.72
9 B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 2001 1.70
10 Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG). Leukemia 2004 1.68
11 ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia 2012 1.68
12 Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol 2004 1.62
13 Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999 1.55
14 Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 2001 1.49
15 The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia 2006 1.47
16 Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A 2000 1.46
17 Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia 2007 1.43
18 Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 1998 1.42
19 APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 1993 1.39
20 Genomic imbalances are rare in hairy cell leukemia. Genes Chromosomes Cancer 1999 1.39
21 Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact. Leukemia 2000 1.39
22 Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood 1998 1.36
23 Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 2002 1.33
24 Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study. Blood 2001 1.31
25 Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med Mol Imaging 2002 1.28
26 [The experience of family carers of older people in the use of support services in Europe: selected findings from the EUROFAMCARE project]. Z Gerontol Geriatr 2006 1.27
27 High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005 1.24
28 CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001 1.23
29 Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 1997 1.19
30 Moxifloxacin prophylaxis in neutropenic patients. J Antimicrob Chemother 2006 1.16
31 Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis. Leukemia 2009 1.16
32 Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling. J Cell Mol Med 2008 1.15
33 TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. Leukemia 2010 1.15
34 Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. Leukemia 2008 1.13
35 Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 1997 1.13
36 Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 1995 1.12
37 Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer 1999 1.11
38 Mapping of the breakpoints on the short arm of chromosome 17 in neoplasms with an i(17q). Genes Chromosomes Cancer 1999 1.10
39 High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 2004 1.09
40 Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation. Leukemia 2004 1.09
41 Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Leukemia 2003 1.08
42 hIan5: the human ortholog to the rat Ian4/Iddm1/lyp is a new member of the Ian family that is overexpressed in B-cell lymphoid malignancies. Genes Immun 2004 1.04
43 The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML. Leukemia 2012 1.02
44 Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids. Leukemia 2007 1.02
45 Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways. Leukemia 2010 1.01
46 High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 1996 1.01
47 Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci U S A 1996 1.00
48 Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 1999 1.00
49 Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J Exp Med 1993 0.99
50 Impact of serum storage conditions on microRNA stability. Leukemia 2012 0.99
51 High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis. Leukemia 2003 0.99
52 Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients. Int J Cancer 2001 0.99
53 Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16). Leukemia 1997 0.97
54 Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 1998 0.96
55 Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance. Leukemia 2012 0.96
56 High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol 1997 0.96
57 Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999 0.94
58 Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001 0.94
59 t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 2000 0.94
60 Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia. Leukemia 2010 0.94
61 Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations. Br J Haematol 2008 0.94
62 Genetic features of B-cell chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000 0.93
63 Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion. Blood 1999 0.93
64 Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia. Leukemia 2009 0.93
65 Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). Leukemia 2007 0.92
66 Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999 0.91
67 Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res 1997 0.91
68 The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia. Leukemia 2008 0.91
69 Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 1994 0.91
70 Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial. Leukemia 2006 0.91
71 Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroups. Leukemia 2011 0.90
72 Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia. Int J Oncol 2006 0.90
73 Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. Int J Cancer 2001 0.88
74 The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice. Leukemia 2011 0.88
75 Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia. Leukemia 2001 0.88
76 Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia. Ann Hematol 1998 0.88
77 Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 1996 0.88
78 Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations. Leukemia 2006 0.87
79 How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistance. Leukemia 2008 0.87
80 Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. Br J Haematol 2001 0.87
81 Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness. Bone Marrow Transplant 2003 0.86
82 Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood 1999 0.86
83 Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosomes Cancer 1995 0.86
84 Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab. Leukemia 2013 0.86
85 Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML. Leukemia 2011 0.85
86 DNA microarray analysis in malignant lymphomas. Ann Hematol 2003 0.85
87 Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia. Leukemia 2012 0.85
88 Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 2000 0.85
89 [Research on health care for the elderly. Prevention, case management, and care for patients with dementia]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006 0.84
90 The ATM gene in the pathogenesis of mantle-cell lymphoma. Ann Oncol 2000 0.83
91 [Interdisciplinary cooperation in primary care of elderly patients--results of results with consequences for general practice]. Gesundheitswesen 1996 0.82
92 Genotypic prognostic markers. Curr Top Microbiol Immunol 2005 0.82
93 Primary gastric apoptosis-rich T-cell lymphoma co-expressing CD4, CD8, and cytotoxic molecules. Virchows Arch 2000 0.82
94 RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia 2016 0.81
95 Risk of false positive results in comparative genomic hybridization. Genes Chromosomes Cancer 2000 0.81
96 Comment on 'Integrative genomic profiling of human prostate cancer'. Leukemia 2010 0.81
97 High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 1993 0.81
98 Evidence for developmental changes of type IV collagen in glomerular basement membrane. Nephron 1987 0.81
99 The German competence network 'Acute and chronic leukemias'. Leukemia 2004 0.81
100 Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia. Leukemia 2009 0.81
101 Detection of trisomy 8 on blood smears using fluorescence in situ hybridization. Leukemia 1993 0.80
102 Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. Leukemia 2002 0.80
103 Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22. Hum Genet 2001 0.80
104 Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). Leukemia 2005 0.79
105 Delineation of genomic regions in chromosome band 7q22 commonly deleted in myeloid leukemias. Recent Results Cancer Res 1998 0.78
106 Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia. Leukemia 2011 0.78
107 Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 1995 0.78
108 Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood. Leukemia 2011 0.77
109 Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer. Anticancer Res 1999 0.77
110 Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens. Cytokines Mol Ther 1996 0.77
111 Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization. Cancer Genet Cytogenet 1996 0.77
112 BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like. Int J Cancer 2000 0.77
113 High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1996 0.77
114 Chronic lymphocytic leukemia: case-based session. Hematology Am Soc Hematol Educ Program 2001 0.76
115 Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation. Eur J Nucl Med 2001 0.76
116 Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone. Br J Haematol 1997 0.76
117 Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia. Br J Haematol 1999 0.76
118 Interphase FISH in chronic lymphoproliferative disorders and comparative genomic hybridisation in the study of lymphomas. Haematologica 1999 0.76
119 Chromosomal aberrations in lymphomas of the gastrointestinal tract. Leuk Lymphoma 1999 0.76
120 BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma. Leukemia 2000 0.76
121 Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group. Ann Oncol 1999 0.75
122 Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization. Stem Cells 1995 0.75
123 [Acute myeloid leukemia]. Internist (Berl) 2015 0.75
124 Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer. Semin Oncol 2000 0.75
125 [Acute myeloid leukemia. Genetic diagnostics and molecular therapy]. Internist (Berl) 2013 0.75
126 [MR tomography detection of bone marrow infiltration by malignant lymphomas]. Onkologie 1989 0.75
127 [Bone marrow involvement in Hodgkin's disease: MR tomography and chemical-shift imaging]. Rofo 1993 0.75
128 Molecular aspects of B-cell lymphomas of the gastrointestinal tract. Clin Lymphoma 2001 0.75
129 [Recurrent cerebral emboli in nonbacterial thrombotic endocarditis]. Dtsch Med Wochenschr 1987 0.75
130 [Enlarged lymph nodes]. Hautarzt 1995 0.75
131 [Lymph node hyperplasia]. Internist (Berl) 1994 0.75
132 Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease. Bone Marrow Transplant 2001 0.75
133 [NMR tomographic imaging of bone marrow infiltrates in malignant lymphoma]. Rofo 1989 0.75
134 Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia. Leuk Lymphoma 2000 0.75
135 High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma. Stem Cells 1995 0.75
136 Fluorescence in situ hybridization in leukemias: 'the FISH are spawning!'. Leukemia 1994 0.75
137 Biological response modifiers render tumor cells susceptible to autologous effector mechanisms by influencing adhesion receptors. Leuk Lymphoma 1993 0.75
138 The rehabilitation process: issues and innovative approaches. WHO Reg Publ Eur Ser 1992 0.75
139 Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia. Semin Oncol 1993 0.75
140 High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears. Cancer Genet Cytogenet 1996 0.75
141 [Clinical research in the "acute and chronic leukemias"competence network ]. Internist (Berl) 2004 0.75
142 Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas. Ann Hematol 2001 0.75
143 [Self-help groups (author's transl)]. MMW Munch Med Wochenschr 1981 0.75
144 [Chronic lymphatic leukemia. Current therapy concepts]. Internist (Berl) 2002 0.75
145 [The competence network "acute and chronic leukemias"]. Dtsch Med Wochenschr 2004 0.75
146 [Concept and practice of hospital after-care--an empirical study of patients in the Bethanien After-Care Clinic]. Offentl Gesundheitswes 1984 0.75
147 Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis. Klin Wochenschr 1989 0.75
148 Detection of bone marrow infiltration by non-Hodgkin's lymphoma--comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging. Klin Wochenschr 1991 0.75
149 Molecular cytogenetic analysis of low-grade B-cell neoplasias: a comparative genomic hybridization study. Recent Results Cancer Res 1998 0.75
150 [Fluorescence in-situ hybridization (FISH). Method and application]. Med Klin (Munich) 1997 0.75
151 Detection of minimal residual disease by polymerase chain reaction in B cell malignancies. Stem Cells 1995 0.75
152 Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferon. Leukemia 1991 0.75